Published • loading... • Updated
HAE Treatment to Prevent Swelling Attacks Wins Approval in Canada
Summary by Angioedema News
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
HAE treatment to prevent swelling attacks wins approval in Canada
Dawnzera (donidalorsen), a preventive therapy used to reduce the risk of swelling attacks in people with hereditary angioedema (HAE), has been approved in Canada for adults and adolescents ages 12 and older. The decision by Health Canada follows Dawnzera’s approval for the same indication in the U.S. last year and in the European Union earlier this […]
This approval, the second one obtained by CELYSTRA Pharma from Health Canada in nine months, offers a new therapeutic option for Canadians.
·Montreal, Canada
Read Full ArticleCoverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
